Mecamylamine- or scopolamine-induced learning impairment: Ameliorated by nefiracetam

Psychopharmacology

Volumn 131, Issue 2, 1997, Pages 130-139

  Woodruff Pak, Diana S ^a,b   Hinchliffe, Richard M ^a  

^a POLISHER RESEARCH INSTITUTE   (United States)

^b TEMPLE UNIVERSITY   (United States)

Author keywords

Aging; Alzheimer's disease; Cognition enhancing; Eyeblink classical conditioning; Memory; Muscarinic receptors; Nicotinic receptors; Nootropic

Indexed keywords

CHOLINERGIC RECEPTOR BLOCKING AGENT; MECAMYLAMINE; MUSCARINIC RECEPTOR; NEFIRACETAM; NICOTINIC RECEPTOR; SCOPOLAMINE;

ALZHEIMER DISEASE; ANIMAL MODEL; ARTICLE; CONDITIONING; CONTROLLED STUDY; EYELID REFLEX; LEARNING DISORDER; NONHUMAN; PRIORITY JOURNAL; RABBIT; SUBCUTANEOUS DRUG ADMINISTRATION;

ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; LEARNING; MECAMYLAMINE; NOOTROPIC AGENTS; PYRROLIDINONES; RABBITS; REACTION TIME; SCOPOLAMINE;

EID: 0030989567     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002130050275     Document Type: Article

References (39)

1. Abe E (1991) Reversal effect of DM-9384 on scopolamine-induced acetylcholine depletion in certain regions of the mouse brain. Psychopharmacology 105:310-316
2. Abe E, Murai S, Saito H et al. (1994) Effects of nefiracetam on deficits in active avoidance response and hippocampal cholinergic and monoaminergic dysfunctions induced by AF64A in mice. J Neural Transm [Gen Sect] 95:179-193
3. Anderson BJ, Steinmetz JE (1994) Cerebellar and brainstem circuits involved in classical eyeblink conditioning. Rev Neurosci 5:251-273
4. Berger TW (1984) Long-term potentiation on hippocampal synaptic transmission affects rate of behavioral learning. Science 224:627-630
5. Berger TW, Berry SD, Thompson RF (1986) Role of the hippocampus in classical conditioning of aversive and appetitive behaviors. In: Isaacson RL, Pribram KH (eds) The hippocampus, vol IV. Plenum Press, New York, pp 203-239
6. Betzing H, Biederman J, Materne C, Neuser V (1980) Pyrrolidin-2-on-1-ylacetic acid 2,6-dimethylanilide, process of preparation and pharmaceutical compositions containing them. German Patent No. DE 2924011
7. Daum I, Schugens MM(1996) On the cerebellum and classical conditioning. Cur Dir Psychol Sci 5:58-61
8. Doyle E, Regan CM, Shiotani T (1993) Nefiracetam (DM-9384) preserves hippocampal neural cell adhesion molecule-mediated memory consolidation process during scopolamine disruption of passive avoidance training in the rat. J Neurochem 61: 266-272
9. Funk KF, Schmidt J (1984) Changes of dopamine metabolism by hypoxia and effect of nootropic drugs. Biomed Biochem Acta 11:1301-1304
10. Hara C, Ogawa N (1990) Characteristic of learning deficit induced by ibotenic acid lesion of the frontal cortex related with the nucleus basalis of Meynert in rats. In: Nagatsu T, Yoshida M (eds) Basic, clinical, and therapeutic aspects of Alzheimer's and Parkinson's disease, vol 1. Plenum Press, New York, pp 735-738
11. Kameyama T, Nabeshima T, Tohyama K et al. (1990) DM-9384, a pyrrolidone derivative, ameliorates basal forebrain lesion-induced amnesia and inhibits cycloheximide-induced decrease in the number of GABA and acetylcholine receptors. In: Nagatsu T, Yoshida M (eds) Basic, clinical, and therapeutic aspects of Alzheimer's and Parkinson's diseases, vol 2. Plenum Press, New York, pp 371-374
12. Lavond DG, Kim JJ, Thompson RF (1993) Mammalian brain substrates of aversive classical conditioning. Annu Rev Psychol 44:317-342
13. McKinney M, Coyle JT, Hedreen JC (1983) Topographic analysis of the innervation of the rat neocortex and hippocampus by the basal forebrain cholinergic system. J Comp Neurol 217: 103-111
14. Marchi M, Besana E, Raiteri M (1990) Oxiracetam increases the release of endogeneous glutamate from depolarized rat hippocampal slices. Eur J Pharmacol 185:247-249
15. Nabeshima T (1994) Ameliorating effects of nefiracetam (DM-9384) on brain dysfunction. Drugs Today 30:357-379
16. Nabeshima T, Noda Y, Tohyama K, Itoh J, Kameyama T (1990) Effects on DM-9384 in a model of amnesia based on animals with GABA-ergic neuronal dysfunctions. Eur J Pharmacol 178:143-149
17. Nabeshima T, Ogawa S, Kameyama T, Shiotani T, Yoshiyuki T, Sakurai T, Hasegawa M, Hasegawa T (1991a) Effects of DM-9384 and aniracetam on learning in normal and basal forebrain-lesioned rats. Res Commun Psychol Psychiatr Behav 16:1-14
18. Nabeshima T, Tohyama K, Kameyama T (1991b) Effects of DM-9384, a pyrrolidone derivative, on alcohol- and chlordizepoxide-induced amnesia in mice. Pharmacol Biochem Behav 36: 233-236
19. Nakamura J, Higashi H, Nishi S, Nakazawa Y (1991) DM-9384, a pyrrolidone derivative, protects the membrane dysfunction induced by deprivation of oxygen and glucose in guinea-pig hippocampal neurons in vitro. Biol Psychiatry 29 [11 Suppl]: Abst P-29-36
20. Nakayama S, Yamada K, Shiotani T et al. (1994) Possible involvement of the activation of calcium channel in the improving effects of nefiracetam (DM-9384) on scopolamine-induced impairment of performance in a passive avoidance task. Jpn J Pharmacol 64[Suppl]: 353
21. Sakurai T, Ojima H, Yamasaki T, Kojima H, Akashi A (1989) Effects of N-(2,6-dimethylphenyl)-2-(2-oxo-1-pyrrolidinyl) acetamide (DM-9384) on learning and memory in rats. Jpn J Pharmacol 50:47-53
22. 3H]acetylcholine in rat brain. Life Sci 38:2111-2120
23. Shiotani T, Tohyama K, Murase K, Ishihara S-I, Kameyama T, Yamasaki T, Hatanaka S, Kojima H, Yoshiyuki T, Nabeshima T (1992) Effects of nefiracetam, DM-9384 on amnesia and decrease in chilineacetyltransferase activity induced by cycloheximide. J Neural Transm [Gen Sect] 90:103-111
24. Solomon PR, Solomon SD, Vander Schaaf E, Perry HE (1983) Altered activity in the hippocampus is more detrimental to classical conditioning than removing the structure. Science 220:329-331
25. Spencer DG Jr, Horvath E, Raber J (1986) Direct autoradiographic determination of M1 and M2 muscarinic acetylcholine receptor distribution in the rat brain: relation to cholinergic nuclei and projections. Brain Res 380:59-68
26. Spignoli G, Pepeu G (1987) Interactions between oxiracetam, quaniracetam and scopolamine on behavior and brain acetylcholine. Pharmacol Biochem Behav 27:491-495
27. Steinmetz JE, Thompson RF (1991) Brain substrates of aversive classical conditioning. In: Madden J IV (ed) Neurobiology of learning, emotion and affect. Raven Press, New York, pp 97-120
28. Sudo K, Hashimoto K, Fujimaki Y, Tachizawa H (1988) Disposition and metabolism of DM-9384, a cyclic GABA derivative, in the rat, dog, and monkey. Psychopharmacology 96 [Suppl.]: Abstr 32.02.05
29. Thompson RF, Krupa DJ (1994) Organization of memory traces in the mammalian brain. Annu Rev Neurosci 17:519-549
30. Watabe S, Yamaguchi H, Ashida S (1993) DM-9384, a new cognition-enhancing agent, increases the turnover of components of the GABAergic system in the rat cerebral cortex. Eur J Pharmacol 238:303-309
31. Woodruff-Pak DS (1995) Evaluation of cognition-enhancing drugs: utility of the model system of eyeblink classical conditioning. CNS Drug Rev 1:107-128
32. Woodruff-Pak DS, Li Y-T (1994) Nefiracetam (DM-9384): effect on classical conditioning in older rabbits. Psychopharmacology 114:200-208
33. Woodruff-Pak DS, Trojanowski JQ (1996) The older rabbit as an animal model: implications for Alzheimer's disease. Neurobiol Aging 17:283-290
34. Woodruff-Pak DS, Lavond DG, Logan CG, Thompson RF (1987) Classical conditioning in 3-, 30- and 45-month-old rabbits: behavioral learning and hippocampal unit activity. Neurobiol Aging 8:101-108
35. Woodruff-Pak DS, Coffin JM, Papka M (1994b) The neurotropic compound, BMY 21502, and classical conditioning of the nictitating membrane response in young and older rabbits. Psychobiology 22:312-319
36. Woodruff-Pak DS, Li Y-T, Kazmi A, Kem WR (1994a) Nicotinic cholinergic system involvement in eyeblink classical conditioning in rabbits. Behav Neurosci 108:486-493
37. Woodruff-Pak DS, Romano S, Papka M (1996) Training to criterion in eyeblink classical conditioning in Alzheimer's disease. Down's syndrome with Alzheimer's disease, and healthy elderly. Behav Neurosci 110:22-29
38. Woodruff-Pak DS, Li Y-T, Hinchliffe RM, Port RL (1997) Hippocampus in delay eyeblink classical conditioning: essential for nefiracetam amelioration of leaning in older rabbits. Brain Res (in press)
39. Yoshii M, Watabe S (1994) Enhancement of neuronal calcium channel currents by the nootropic agent, nefiracetam (DM-9384), in NG108-14 cells. Brain Res 642:123-131